PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616749
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1616749
The Global EPA/DHA (Omega 3) Ingredients Market was valued at USD 3 billion in 2023. Projections indicate a growth of 6.5% CAGR from 2024 to 2032, primarily fueled by heightened consumer awareness regarding the health advantages of omega-3 fatty acids. Additionally, collaborations among major companies are bolstering production capabilities. The market is witnessing robust growth, largely attributed to the surging demand for functional foods and dietary supplements. With consumers placing a premium on health, the appetite for premium omega-3 ingredients is set to escalate.
This market is on the brink of significant expansion, spurred by a heightened consumer emphasis on health and wellness. The escalating recognition of omega-3 fatty acids' health benefits especially in mitigating cardiovascular risks, bolstering cognitive function, and managing inflammation is propelling their demand across diverse applications. The industry is segmented into product, source, application, and region. Driven by their superior bioavailability and cost-effectiveness, the demand for anchovies and sardine oil is projected to grow at a rate exceeding 9.2% CAGR from 2024 to 2032. Serving as primary sources for EPA/DHA ingredients, anchovies, and sardines, being small oily fish rich in omega-3s, are favored for extraction.
As the omega-3 ingredient market burgeons, producers are increasingly adopting sustainable fishing practices and certifications to cater to the rising consumer demand for responsibly sourced products. In 2023, the dietary supplements segment commanded a notable share of the EPA/DHA ingredients market. Projections suggest this segment will grow at a rate surpassing 6.5% CAGR from 2024 to 2032. The convenience of dietary supplements in promoting health and wellness is driving the demand for omega-3 ingredients in this arena. Notably, EPA/DHA supplements are in high demand among those aiming to enhance cardiovascular health, cognitive abilities, and joint flexibility.
Market Scope | |
---|---|
Start Year | 2023 |
Forecast Year | 2024-2032 |
Start Value | $3 Billion |
Forecast Value | $5.4 Billion |
CAGR | 6.5% |
In 2023, the Asia Pacific held a substantial portion of the EPA/DHA ingredients market. By 2032, it is projected to reach a valuation of USD 1.5 billion. Key drivers of this growth include a rising awareness of omega-3 benefits in nations like China, Japan, and India. Furthermore, as chronic diseases become more prevalent and the middle class expands with increased disposable income, there is a notable uptick in demand for EPA/DHA ingredients in both dietary supplements and functional foods.